The multicomponent medication lymphomyosot improves the outcome of experimental lymphedema

Lymphatic Research and Biology

Volumn 11, Issue 2, 2013, Pages 81-92

  Keim, Alex P ^a   Slis, Justin R ^a   Mendez, Uziel ^a   Stroup, Emily M ^a   Burmeister, Yvonne ^c   Tsolaki, Natalie ^d   Gailing, Oliver ^b   Goldman, Jeremy ^a  

^a Michigan Technological University   (United States)

^b MICHIGAN TECHNOLOGICAL UNIVERSITY   (United States)

^c Biologische Heilmittel Heel GmbH   (Germany)

^d NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; LYMPHOMYOSOT; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AXILLARY LYMPH NODE; CAPILLARY; CELL INFILTRATION; CONTROLLED STUDY; FEMALE; LYMPH VESSEL; LYMPHANGIOGENESIS; LYMPHEDEMA; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SURGICAL WOUND; TAIL; TISSUE REGENERATION; WOUND CLOSURE; WOUND HEALING;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; LYMPHEDEMA; MACROPHAGES; MICE; MICE, INBRED BALB C; PLANT EXTRACTS; WOUND HEALING;

EID: 84879332786     PISSN: 15396851     EISSN: 15578585     Source Type: Journal    
DOI: 10.1089/lrb.2012.0024     Document Type: Article

References (98)

1. Lumachi F, Basso SM, Bonamini M, et al. Incidence of arm lymphoedema following sentinel node biopsy, axillary sampling and axillary dissection in patients with breast cancer. In Vivo 2009;23:1017-1020.
2. Seifart U, Albert US, Heim ME, et al. Lymphedema in patients with breast cancer-A consensus regarding diagnostics and therapy in patients with postoperative lymphedema after primary breast cancer. Rehabilitation (Stuttg Dec 2007; 46:340-348.
3. Leidenius M, Leivonen M, Vironen J, von Smitten K. The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance. J Surg Oncol 2005;92:23-31. (Pubitemid 41416425)
4. Paskett ED, Stark N. Lymphedema: Knowledge, treatment, and impact among breast cancer survivors. Breast J 2000; 6:373-378. (Pubitemid 32046230)
5. Cemal Y, Pusic A, Mehrara BJ. Preventative measures for lymphedema: separating fact from fiction. J Am Coll Surg 2011;213:543-551.
6. Chachaj A, Malyszczak K, Pyszel K, et al. Physical and psychological impairments of women with upper limb lymphedema following breast cancer treatment. Psychooncology 2010;19:299-305.
7. Hamner JB, Fleming MD. Lymphedema therapy reduces the volume of edema and pain in patients with breast cancer. Ann Surg Oncol 2007;14:1904-1908. (Pubitemid 46870933)
8. Suami H, Pan WR, Taylor GI. The lymphatics of the skin filled by a dermal backflow: An observation in a scarred cadaver leg. Lymphology 2007;40:122-126. (Pubitemid 350060119)
9. Uzarski J, Drelles MB, Gibbs SE, et al. The resolution of lymphedema by interstitial flow in the mouse tail skin. Am J Physiol Heart Circ Physiol 2008;294:H1326-1334. (Pubitemid 351468731)
10. Avraham T, Clavin NW, Daluvoy SV, et al. Fibrosis is a key inhibitor of lymphatic regeneration. Plast Reconstr Surg 2009;124:438-450.
11. Clavin NW, Avraham T, Fernandez J, et al. TGF-beta1 is a negative regulator of lymphatic regeneration during wound repair. Am J Physiol Heart Circ Physiol 2008;295:H2113-2127.
12. Avraham T, Yan A, Zampell JC, et al. Radiation therapy causes loss of dermal lymphatic vessels and interferes with lymphatic function by TGF-beta1-mediated tissue fibrosis. Am J Physiol Cell Physiol 2010;299:C589-605.
13. Carlisle EM. In vivo requirement for silicon in articular cartilage and connective tissue formation in the chick. J Nutr 1976;106:478-484.
14. Goldman J, Conley KA, Raehl A, et al. Regulation of lymphatic capillary regeneration by interstitial flow in skin. Am J Physiol Heart Circ Physiol 2007;292:H2176-2183. (Pubitemid 47084597)
15. Stramer BM, Mori R, Martin P. The inflammation-fibrosis link? A Jekyll and Hyde role for blood cells during wound repair. J Invest Dermatol 2007;127:1009-1017. (Pubitemid 46625163)
16. Shaw TJ, Martin P. Wound repair at a glance. J Cell Sci 2009;122:3209-3213.
17. Nathan C, Ding A. Nonresolving inflammation. Cell 2010; 140:871-882.
18. Chen GY, Nunez G. Sterile inflammation: Sensing and reacting to damage. Nat Rev Immunol 2010;10:826-837.
19. Ishida Y, Gao JL, Murphy PM. Chemokine receptor CX3CR1 mediates skin wound healing by promoting macrophage and fibroblast accumulation and function. J Immunol 2008; 180:569-579.
20. Mercandetti M. Wound healing and repair. http://emedicine .medscape.com/article/1298129-overview. Accessed 29 May 2012.
21. Wilgus TA. Immune cells in the healing skin wound: Influential players at each stage of repair. Pharmacol Res 2008;58: 112-116.
22. Eming SA, Werner S, Bugnon P, et al. Accelerated wound closure in mice deficient for interleukin-10. Am J Pathol 2007;170:188-202. (Pubitemid 47339199)
23. Lucas T, Waisman A, Ranjan R, et al. Differential roles of macrophages in diverse phases of skin repair. J Immunol 2010;184:3964-3977.
24. Serhan CN, Savill J. Resolution of inflammation: The beginning programs the end. Nat Immunol 2005;6:1191-1197. (Pubitemid 43045627)
25. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: Dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008;8:349-361. (Pubitemid 351595216)
26. Serhan CN, Brain SD, Buckley CD, et al. Resolution of inflammation: State of the art, definitions and terms. FASEB J 2007;21:325-332. (Pubitemid 46213480)
27. Perretti M, Dalli J. Exploiting the Annexin A1 pathway for the development of novel anti-inflammatory therapeutics. Br J Pharmacol 2009;158:936-946.
28. Von Der Weid PY, Rehal S. Lymphatic pump function in the inflamed gut. Ann NY Acad Sci 2010;1207:E69-74.
29. von der Weid PY, Rehal S, Dyrda P, et al. Mechanisms of VIP-induced inhibition of the lymphatic vessel pump. J Physiol 2012;590:2677-2691.
30. Moyseyenko V CV. Effectiveness and tolerability of Lymphomyosot: Solution for injection in treating oedemas and swellings of thrombotic or inflammatory aetiology in general clinical practice. Eur J Integ Med 2009;1.
31. Eiber A KP, Weiser M. Diabetic peripheral neuropathy. Adjuvant homeopathic treatment enhances the effects of conventional therapy. Der Allgemeinarzt. 2003;25:610-614.
32. Dietz A-R. Possibilities for lymph therapy with diabetic polyneuropathy. Intl J Biomed Res Ther 2000;299:4-9.
33. Zenner SMH. Therapeutic use of Lymphomyosot. Results of a multicentre use observation study on 3,512 patients. Biol Ther 1990;8.
34. Gabay O, Sanchez C, Salvat C, et al. Stigmasterol: A phytosterol with potential anti-osteoarthritic properties. Osteoarth Cartil 2010;18:106-116.
35. Guo YJ, Zhao L, Li XF, et al. Effect of Corilagin on antiinflammation in HSV-1 encephalitis and HSV-1 infected microglias. Eur J Pharmacol 2010;635:79-86.
36. Ikeda Y, Murakami A, Fujimura Y, et al. Aggregated ursolic acid, a natural triterpenoid, induces IL-1beta release from murine peritoneal macrophages: Role of CD36. J Immunol 2007;178:4854-4864. (Pubitemid 46595267)
37. Jeong HJ, Koo HN, Na HJ, et al. Inhibition of TNF-alpha and IL-6 production by Aucubin through blockade of NFkappaB activation RBL-2H3 mast cells. Cytokine 2002;18: 252-259.
38. Moon MK, Lee YJ, Kim JS, Kang DG, Lee HS. Effect of caffeic acid on tumor necrosis factor-alpha-induced vascular inflammation in human umbilical vein endothelial cells. Biol Pharm Bull 2009;32:1371-1377.
39. Ahmad SF, Khan B, Bani S, Suri KA, Satti NK, Qazi GN. Amelioration of adjuvant-induced arthritis by ursolic acid through altered Th1/Th2 cytokine production. Pharmacol Res 2006;53:233-240. (Pubitemid 43247535)
40. Schmolz MMH. Immunopharmacological effect of individual antihomotoxic agents in Lymphomyosot N. Biol Med 2001;30:177-183.
41. Song HS, Park TW, Sohn UD, et al. The effect of caffeic acid on wound healing in skin-incised mice. Korean J Physiol Pharmacol 2008;12:343-347.
42. Huang ST, Wang CY, Yang RC, et al. Ellagic acid, the active compound of Phyllanthus urinaria, exerts in vivo antiangiogenic effect and inhibits MMP-2 activity. Evid Based Complement Alternat Med. 2011;2011:215035.
43. Ho JN, Lee YH, Park JS, et al. Protective effects of aucubin isolated from Eucommia ulmoides against UVB-induced oxidative stress in human skin fibroblasts. Biol Pharm Bull 2005;28:1244-1248. (Pubitemid 41327595)
44. Stevenson PC, Simmonds MS, Sampson J, Houghton PJ, Grice P. Wound healing activity of acylated iridoid glycosides from Scrophularia nodosa. Phytother Res 2002;16:33-35. (Pubitemid 34116692)
45. Ozturk N, Korkmaz S, Ozturk Y, Baser KH. Effects of gentiopicroside, sweroside and swertiamarine, secoiridoids from gentian (Gentiana lutea ssp. symphyandra), on cultured chicken embryonic fibroblasts. Planta Med 2006;72: 289-294.
46. Europe Co. European Pharmacopoeia. Strasbourg: Council of Europe; 2010.
47. Rutkowski JM, Moya M, Johannes J, Goldman J, Swartz MA. Secondary lymphedema in the mouse tail: Lymphatic hyperplasia, VEGF-C upregulation, and the protective role of MMP-9. Microvasc Res 2006;72:161-171. (Pubitemid 44692751)
48. Swartz MA, Kaipainen A, Netti PA, et al. Mechanics of interstitial-lymphatic fluid transport: Theoretical foundation and experimental validation. J Biomech 1999;32:1297-1307. (Pubitemid 29490874)
49. Roberts MA, Mendez U, Gilbert RJ, Keim AP, Goldman J. Increased hyaluronan expression at distinct time points in acute lymphedema. Lymphat Res Biol 2012;10:122-128.
50. Ongstad EL, Bouta EM, Roberts JE, et al. Lymphangiogenesis-independent resolution of experimental edema. Am J Physiol Heart Circ Physiol 2010;299:H46-54.
51. Boardman KC, Swartz MA. Interstitial flow as a guide for lymphangiogenesis. Circ Res 2003;92:801-808. (Pubitemid 36457646)
52. Goldman J, Le TX, Skobe M, Swartz MA. Overexpression of VEGF-C causes transient lymphatic hyperplasia but not increased lymphangiogenesis in regenerating skin. Circ Res 2005;96:1193-1199. (Pubitemid 40827695)
53. Pytowski B, Goldman J, Persaud K, et al. Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody. J Natl Cancer Inst 2005; 97:14-21.
54. Rutkowski JM, Boardman KC, Swartz MA. Characterization of lymphangiogenesis in a model of adult skin regeneration. Am J Physiol Heart Circ Physiol 2006;291:H1402-1410. (Pubitemid 44343687)
55. Goldman J, Rutkowski JM, Shields JD, et al. Cooperative and redundant roles of VEGFR-2 and VEGFR-3 signaling in adult lymphangiogenesis. FASEB J 2007;21:1003-1012. (Pubitemid 46495690)
56. Tammela T, Saaristo A, Holopainen T, et al. Therapeutic differentiation and maturation of lymphatic vessels after lymph node dissection and transplantation. Nat Med 2007; 13:1458-1466. (Pubitemid 350224251)
57. Austyn JM, Gordon S. F4/80, a monoclonal antibody directed specifically against the mouse macrophage. Eur J Immunol 1981;11:805-815. (Pubitemid 12237981)
58. Kwon S, Sevick-Muraca EM. Noninvasive quantitative imaging of lymph function in mice. Lymphat Res Biol 2007; 5:219-231.
59. Sevick-Muraca EM, Sharma R, Rasmussen JC, et al. Imaging of lymph flow in breast cancer patients after microdose administration of a near-infrared fluorophore: feasibility study. Radiology 2008;246:734-741.
60. Sharma R, Wang W, Rasmussen JC, et al. Quantitative imaging of lymph function. Am J Physiol Heart Circ Physiol 2007;292:H3109-3118. (Pubitemid 47084566)
61. Liu R, Zhang L, Lan X, et al. Protection by borneol on cortical neurons against oxygen-glucose deprivation/reperfusion: Involvement of anti-oxidation and antiinflammation through nuclear transcription factor kappaappaB signaling pathway. Neuroscience 2011;176:408-419.
62. Rose P, Won YK, Ong CN, Whiteman M. Beta-phenylethyl and 8-methylsulphinyloctyl isothiocyanates, constituents of watercress, suppress LPS induced production of nitric oxide and prostaglandin E2 in RAW 264.7 macrophages. Nitric Oxide 2005;12:237-243. (Pubitemid 40732393)
63. Umesalma S, Sudhandiran G. Differential inhibitory effects of the polyphenol ellagic acid on inflammatory mediators NF-kappaB, iNOS, COX-2, TNF-alpha, and IL-6 in 1,2-dimethylhydrazine-induced rat colon carcinogenesis. Basic Clin Pharmacol Toxicol 2010;107:650-655.
64. Okubo T, Washida K, Murakami A. Phenethyl isothiocyanate suppresses nitric oxide production via inhibition of phosphoinositide 3-kinase/Akt-induced IFN-gamma secretion in LPS-activated peritoneal macrophages. Mol Nutr Food Res 2010;54:1351-1360.
65. Zhao L, Zhang SL, Tao JY, et al. Preliminary exploration on anti-inflammatory mechanism of Corilagin (beta-1-Ogalloyl-3,6-(R)- hexahydroxydiphenoyl-D-glucose) in vitro. Int Immunopharmacol 2008;8:1059-1064.
66. Zhao Z, Shin HS, Satsu H, Totsuka M, Shimizu M. 5-Caffeoylquinic acid and caffeic acid down-regulate the oxidative stress-and TNF-alpha-induced secretion of interleukin-8 from Caco-2 cells. J Agric Food Chem 2008; 56:3863-3868. (Pubitemid 351860195)
67. Chao CY, Mong MC, Chan KC, Yin MC. Anti-glycative and anti-inflammatory effects of caffeic acid and ellagic acid in kidney of diabetic mice. Mol Nutr Food Res 2010;54:388-395.
68. Chao PC, Hsu CC, Yin MC. Anti-inflammatory and anticoagulatory activities of caffeic acid and ellagic acid in cardiac tissue of diabetic mice. Nutr Metab (Lond) 2009;6:33.
69. Anauate MC, Torres LM, de Mello SB. Effect of isolated fractions of Harpagophytum procumbens D.C. (devil's claw) on COX-1, COX-2 activity and nitric oxide production on whole-blood assay. Phytother Res 2010;24:1365-1369.
70. Karonen M, Hamalainen M, Nieminen R, et al. Phenolic extractives from the bark of Pinus sylvestris L. and their effects on inflammatory mediators nitric oxide and prostaglandin E2. J Agric Food Chem 2004;52:7532-7540.
71. Choi YH, Yan GH. Ellagic Acid attenuates immunoglobulin E-mediated allergic response in mast cells. Biol Pharm Bull 2009;32:1118-1121.
72. Litjens NH, Rademaker M, Ravensbergen B, et al. Monomethylfumarate affects polarization of monocyte-derived dendritic cells resulting in down-regulated Th1 lymphocyte responses. Eur J Immunol 2004;34:565-575. (Pubitemid 39255966)
73. Schilling S, Goelz S, Linker R, Luehder F, Gold R. Fumaric acid esters are effective in chronic experimental autoimmune encephalomyelitis and suppress macrophage infiltration. Clin Exp Immunol 2006;145:101-107. (Pubitemid 43893938)
74. Ikeda Y, Murakami A, Ohigashi H. Ursolic acid promotes the release of macrophage migration inhibitory factor via ERK2 activation in resting mouse macrophages. Biochem Pharmacol 2005;70:1497-1505. (Pubitemid 41483460)
75. Spelman K, Aldag R, Hamman A, et al. Traditional herbal remedies that influence cell adhesion molecule activity. Phytother Res 2011;25:473-483.
76. Picerno P, Autore G, Marzocco S, Meloni M, Sanogo R, Aquino RP. Anti-inflammatory activity of verminoside from Kigelia africana and evaluation of cutaneous irritation in cell cultures and reconstituted human epidermis. J Nat Prod 2005;68:1610-1614. (Pubitemid 41789566)
77. Kim SR, Koo KA, Sung SH, Ma CJ, Yoon JS, Kim YC. Iridoids from Scrophularia buergeriana attenuate glutamateinduced neurotoxicity in rat cortical cultures. J Neurosci Res 2003;74:948-955. (Pubitemid 37492954)
78. Lee S, Park HS, Notsu Y, et al. Effects of hyperin, isoquercitrin and quercetin on lipopolysaccharide-induced nitrite production in rat peritoneal macrophages. Phytother Res 2008;22:1552-1556. (Pubitemid 352789629)
79. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 2008;8:958-969.
80. Peters T, Sindrilaru A, Hinz B, et al. Wound-healing defect of CD18(-/-) mice due to a decrease in TGF-beta1 and myofibroblast differentiation. EMBO J 2005;24:3400-3410. (Pubitemid 41486778)
81. von der Weid PY, Muthuchamy M. Regulatory mechanisms in lymphatic vessel contraction under normal and inflammatory conditions. Pathophysiology 2010;17:263-276.
82. Agyare C, Lechtenberg M, Deters A, Petereit F, Hensel A. Ellagitannins from Phyllanthus muellerianus (Kuntze) Exell: Geraniin and furosin stimulate cellular activity, differentiation and collagen synthesis of human skin keratinocytes and dermal fibroblasts. Phytomedicine 2011;18:617-624.
83. Cai Y, Chen T, Xu Q. Astilbin suppresses collagen-induced arthritis via the dysfunction of lymphocytes. Inflamm Res 2003;52:334-340. (Pubitemid 36995158)
84. Dai JP, Chen J, Bei YF, Han BX, Wang S. Influence of borneol on primary mice oral fibroblasts: A penetration enhancer may be used in oral submucous fibrosis. J Oral Pathol Med 2009;38:276-281.
85. Mai LM, Lin CY, Chen CY, Tsai YC. Synergistic effect of bismuth subgallate and borneol, the major components of Sulbogin, on the healing of skin wound. Biomaterials 2003; 24:3005-3012.
86. Midwood KS, Williams LV, Schwarzbauer JE. Tissue repair and the dynamics of the extracellular matrix. Int J Biochem Cell Biol 2004;36:1031-1037. (Pubitemid 38501555)
87. Murado MA, Vazquez JA. The notion of hormesis and the dose-response theory: A unified approach. J Theor Biol 2007; 244:489-499. (Pubitemid 46027157)
88. Calabrese EJ, Baldwin LA. Hormesis: U-shaped dose responses and their centrality in toxicology. Trends Pharmacol Sci 2001;22:285-291. (Pubitemid 32536728)
89. Calabrese EJ, Baldwin LA. The frequency of U-shaped dose responses in the toxicological literature. Toxicol Sci 2001; 62:330-338. (Pubitemid 32707748)
90. Zhang X, Kan Q, Fu Y, Liu S, Dai Z, Dong Y. Noradrenergic activity regulated dexamethasone-induced increase of 5-HT(3) receptor-mediated glutamate release in the rat's prelimbic cortex. Biochim Biophys Acta 2012;1823:2157-2167.
91. Baldi E, Bucherelli C. The inverted "u-shaped" dose-effect relationships in learning and memory: Modulation of arousal and consolidation. Nonlinearity Biol Toxicol Med 2005; 3:9-21.
92. Vandenberg LN, Colborn T, Hayes TB, et al. Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses. Endocr Rev 2012;33:378-455.
93. Kendig EL, Le HH, Belcher SM. Defining hormesis: Evaluation of a complex concentration response phenomenon. Int J Toxicol 2010;29:235-246.
94. Calabrese E, Iavicoli I, Calabrese V. Hormesis: Its impact on medicine and health. Hum Exp Toxicol 2013;32:120-152.
95. Mushak P. How prevalent is chemical hormesis in the natural and experimental worlds? Sci Total Environ 2013; 443:573-581.
96. Thirugnanasambandam N, Grundey J, Paulus W, Nitsche MA. Dose-dependent nonlinear effect of L-DOPA on paired associative stimulation-induced neuroplasticity in humans. J Neurosci 2011;31:5294-5299.
97. Horiguchi M, Hannaway KE, Adelekun AE, Huang M, Jayathilake K, Meltzer HY. D(1) receptor agonists reverse the subchronic phencyclidine (PCP)-induced novel object recognition (NOR) deficit in female rats. Behav Brain Res 2013; 238:36-43.
98. Serafini P, Carbley R, Noonan KA, Tan G, Bronte V, Borrello I. High-dose granulocyte-macrophage colony-stimulating factor-producing vaccines impair the immune response through the recruitment of myeloid suppressor cells. Cancer Res 2004;64:6337-6343. (Pubitemid 39129439)